The Leeds Teaching Hospitals NHS Trust


Award success for Dr Quentin Hill, Haematology Consultant at Leeds Teaching Hospitals

10 March 2021

Consultant Haematologist Dr Quentin Hill was selected as an award winner at the 2020 British Society of Haematology (BSH) Awards. Dr Hill was recognised for research success and received the prestigious NIHR – BSH Consultant Researcher of the Year Award. This award recognises achievements in haematology research.

Dr Hill is a full time clinical consultant based at the Leeds Teaching Hospitals NHS Trust. In addition to his role at the Hospital he is an Honorary Clinical Associate Professor at the University of Leeds. Dr Hill’s main research interests are autoimmune haematology and red cell disorders.

The Award highlights the importance of research and clinical trials undertaken by clinical staff. Dr Hill holds several research grants. One study investigates whether a variable in patients’ blood (Fcg receptor polymorphisms), predicts whether adult patients with primary immune thrombocytopenia (ITP) are likely to respond to expensive medication.  A further project explores how immune dysregulation in ITP may result in fatigue.

Dr Hill said: “I was delighted to receive the award which was a real honour. I would like to highlight that running clinical trials is very much a team effort. I am supported by, and grateful to, our fantastic haematology clinical trials team, including Catherine Norton, trials co-ordinator and nurses, David Buchanan and Stewart McConnell.

 In the 3 years prior to the award, Dr Hill published 19 peer reviewed papers, including: first author of two BSH guidelines (both top 10 most downloaded articles in the British Journal of Haematology 2017), a BSH good practice paper and an international consensus on management of Autoimmune Haemolytic Anaemia (AIHA).”

As a member of the NIHR Haematology National Specialty Group Dr Hill reviews studies to determine their suitability for clinical research network (CRN) support and inclusion on the NIHR CRN Portfolio. Dr Hill is co-lead for the NIHR BioResource haematology workstream “Refractoriness to first-line treatment for blood cell autoimmunity”.  As founding UK ITP forum secretary from 2011 and current chair, Dr Hill has sought to ensure that research delivery is embedded in practice. 

Dr Hill is local Principle Investigator for a number of clinical trials and registry studies.  He has also taken roles in trial oversight or steering committees for 3 clinical trials, 1 national registry (the UK ITP registry) and a global registry (the CADENCE registry for patients with Cold Agglutinin Disease).